European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
about
Implantable defibrillators versus medical therapy for cardiac channelopathiesImplantable defibrillators versus medical therapy for cardiac channelopathiesCombined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series.Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.REmote SUpervision to Decrease HospitaLization RaTe. Unified and integrated platform for data collected from devices manufactured by different companies: Design and rationale of the RESULT study.Economic evaluations of implantable cardioverter defibrillators: a systematic review.The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance.Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts SymposiumThe deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention.Long-term performance of the St Jude Riata 1580-1582 ICD lead family.Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.Deactivation of implantable cardioverter-defibrillators at end of life.Sudden cardiac death: a critical appraisal of the implantable cardioverter defibrillator.Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods.Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres.Effect of Therapeutic Ionizing Radiation on Implantable Electronic Devices: Systematic Review and Practical Guidance.Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy.Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences?Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment.Should physicians instead of industry representatives be the main actor of cardiac implantable electronic device follow-up? (Super Follow-up).Implantable cardioverter defibrillators: even better than we thought?Fully digital data processing during cardiovascular implantable electronic device follow-up in a high-volume tertiary center.Pacemaker follow-up after device replacement.Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.Normativity under change: Older persons with implantable cardioverter defibrillator.Safety of Bioelectrical Impedance Analysis in Patients Equipped With Implantable Cardioverter Defibrillators.Refusing Implantable Cardioverter Defibrillator (ICD) Replacement in Elderly Persons-The Same as Giving Up Life: A Qualitative Study.[Magnetic resonance imaging and implantable cardiac devices. Current status and future perspectives of MR-compatible systems].Long-term outcomes of heart failure patients who received primary prevention implantable cardioverter-defibrillator: An observational study.
P2860
Q24186596-8A5986B6-1144-4D61-9DD8-151DBB947BDDQ24194254-C27776AA-B1FF-4151-B455-1DCBCF81FD9BQ30444028-D0A35EB4-76AE-446C-BF46-2DFB9DDE7CB0Q30863604-96CD1AE3-4CB2-4275-8898-A5D6E5485F73Q31151338-E184CBA5-415E-4034-9B69-E294FF82BED2Q33164873-D0945E67-94F5-4457-A7DE-3A242076E990Q35539464-CCA52AAD-3960-40FF-AE6C-85988930EB3FQ35883082-B52CFD13-5ABC-414C-A614-1721BDE68C2BQ36241346-4D5D6B7D-7D0B-40C8-829A-755A1CFA787FQ36458785-1DC4669C-8C0D-4F90-903B-502F07E2990AQ36627317-FEF96F37-5221-487A-A24C-85C195501C86Q36859305-1A816364-4AFD-4E09-B6D5-BF77ED58D984Q38158220-F27F1223-1461-46A4-8F74-98AEFF192FB2Q38174217-8E78632D-31E5-48BC-A5AC-DF7016403D53Q38252697-0B8311F2-287A-4406-813F-AF247BA1A14BQ38357882-901D9502-4D41-4E25-B812-8455804E8B56Q38411076-2E3BE3B8-2093-4C4F-9FC4-FA02F79CF584Q38655221-D8E34808-D1E9-49CF-9732-8283EE44AC7CQ38871498-BD6B2653-9551-4A1B-9EB6-8DC83B6BBE88Q38872391-183DFE2B-BDDC-4FE9-95FD-E9EF0FF9722CQ38990436-E72F5614-9A99-4EE8-90B1-561D74882014Q40361284-60D386AE-9293-4E38-8570-B602DBE65374Q41026695-8B725E08-D253-494C-B3BF-B7509289A5E9Q42354831-B329AD06-5623-4DAB-B7D7-E6539C79F876Q42375063-54204DCF-91C5-4B46-94C7-442E9FB76203Q47255395-2B371C68-C0EE-472E-9F8B-EDDE3A69FB50Q50089222-98E099AE-491A-4E1A-916D-F5999AFD748AQ50977558-13E6ABD3-1154-4E6E-9E7B-2840F7D9936CQ51502746-319E0E9C-53B5-45B2-A390-0A0F08EAF1B5Q51824803-C5301949-3B38-4606-B75D-AD75F98CCFF9Q52889277-4AE3AD54-AA78-4D00-A9BE-1E4AEEB87E0AQ54958106-ECB5E7C0-86A4-4FC2-AA17-F9D19A111D7D
P2860
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@en
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@nl
type
label
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@en
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@nl
prefLabel
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@en
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@nl
P2860
P356
P1433
P1476
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
@en
P2093
A John Camm
Seah Nisam
P2860
P304
P356
10.1093/EUROPACE/EUQ282
P577
2010-08-01T00:00:00Z